Issue Date: January 21, 2008
Wyeth Plant Goes To Newcomer Akrimax
Wyeth has sold its finished drug manufacturing and packaging plant in Rouses Point, N.Y., to Akrimax Pharmaceuticals, a new drug company. The sale agreement includes a transition period lasting until the end of 2009. During that time, Akrimax plans to introduce its own drugs and contract-manufactured products into the facility. The plant employs nearly 800 people. The sale does not include a 90-employee chemical development pilot plant, which Wyeth will continue to operate.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society